Prescription Pattern of Oral Antidiabetic Medications in Type II Diabetes Mellitus Patients with Heart Failure: A Retrospective Observational Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 700
- 试验地点
- 1
- 主要终点
- This study will investigate the annual rate of prescriptions of different therapeutic classes of oral antidiabetics in T2DM patients with Heart Failure
研究概览
简要总结
This retrospective observational study aims to evaluate the prescribing patterns of oral antidiabetic medications among patients diagnosed with Type 2 Diabetes Mellitus and Heart Failure. The study will be conducted over a six-month period using data from inpatients recorded between January 2019 and August 2025, sourced from the Medical Records Department. The primary objective is to assess the utilization of different therapeutic classes of oral antidiabetics (e.g., Metformin, DPP-4 inhibitors, SGLT2 inhibitors, Sulfonylureas) in T2DM patients with Heart Failure and to analyze demographic and clinical factors influencing prescription trends. Data will be collected using a structured data collection form, and ethical clearance will be obtained prior to study commencement. Statistical analysis will involve descriptive methods using SPSS version 29.0. The study aims to identify adherence to evidence-based guidelines and uncover any inconsistencies in real-world prescribing practices.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 85.00 Year(s)(—)
- 性别
- All
入选标准
- •Aged greater than 18 years Patients with T2DM and HF Patients administered on OHAs with/without insulin At least one prescription for an oral diabetes medication.
排除标准
- •ESRD with dialysis Patient with Type-1 Diabetes Mellitus Death Pregnant women.
结局指标
主要结局
This study will investigate the annual rate of prescriptions of different therapeutic classes of oral antidiabetics in T2DM patients with Heart Failure
时间窗: January 2019-August 2025
次要结局
- This study will investigate the factors associated with the prescription of different therapeutic classes of oral antidiabetic drugs in T2DM patients with Heart Failure:(Age)
研究者
Wilona Trinal D souza
NGSM Institute of Pharmaceutical Sciences
